Zomedica launches two canine assays for TRUFORMA, including NT-proBNP for heart disease and progesterone for breeding. The assays provide reference lab-level accuracy in-clinic, enhancing diagnostics ...
On Monday, Zomedica Corp. (AMEX:ZOM) disclosed the launch of two new canine assays for its TRUFORMA In-Clinic Biosensor Testing Platform. Zomedica’s progesterone test quantitatively measures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback